With the share price as a guide, I was anticipating some negative news about fee indexation in Australia or the reintroduction of a fee freeze in the US.
There also at least a portion of the share price decline attributable to the rise in interest rate expectations this year. US 10 year going ~3.8% to ~4.5% this year. Their business model is buying pathology businesses with debt.
Regardless, I did buy a few more today.
With the share price as a guide, I was anticipating some...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.02 |
Change
0.270(1.05%) |
Mkt cap ! $12.49B | |||
| Open | High | Low | Value | Volume |
| $25.81 | $26.09 | $25.70 | $6.918M | 266.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 699 | $26.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.03 | 2189 | 22 |
View Market Depth
| Last trade - 12.55pm 05/07/2024 (20 minute delay) ? |
| SHL (ASX) Chart |